These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15083197)

  • 1. Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cells.
    Chan RC; Pang XW; Wang YD; Chen WF; Xie Y
    Br J Cancer; 2004 Apr; 90(8):1636-43. PubMed ID: 15083197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
    González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
    Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene.
    Lin L; Wei J; Chen Y; Huang A; Li KK; Zhang W
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):281-9. PubMed ID: 24322180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cytotoxic T cell response against HCA661 positive cancer cells through activation with novel HLA-A *0201 restricted epitopes.
    Pang PH; Chan KT; Tse LY; Chan RC; Cheung YK; Sin FW; Guo ZH; Xie Y
    Cancer Lett; 2007 Oct; 256(2):178-85. PubMed ID: 17624664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immune response of HBsAg gene-modified dendritic cell-based vaccine in HepG2. 2. 15 hepatocellular carcinoma cells].
    Yang JY; Liu WC; Cao DY; Si XM; Teng ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):728-32. PubMed ID: 18396682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-loaded dendritic cells triggers a specific cytotoxic T lymphocytes immune response against hepatocellular carcinoma: in vitro study.
    El-Ashmawy NE; El-Zamarany EA; Khedr EG; El-Bahrawy HA; El-Feky OA
    Clin Transl Oncol; 2019 May; 21(5):636-645. PubMed ID: 30368725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antitumor cytotoxic T lymphocyte response induced by dendritic cells transduced with DeltaNp73alpha recombinant adenovirus.
    Hu Y; He Y; Srivenugopal KS; Fan S; Jiang Y
    Oncol Rep; 2007 Nov; 18(5):1085-91. PubMed ID: 17914557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
    Chen Y; Huang A; Gao M; Yan Y; Zhang W
    Int J Mol Med; 2013 Dec; 32(6):1366-72. PubMed ID: 24085111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells.
    Liu X; Li J; Liu Y; Ding J; Tong Z; Liu Y; Zhou Y; Liu Y
    Cell Immunol; 2016 Feb; 300():46-53. PubMed ID: 26702740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
    Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
    Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant mammaglobin A adenovirus-infected dendritic cells induce mammaglobin A-specific CD8+ cytotoxic T lymphocytes against breast cancer cells in vitro.
    Cui H; Zhang W; Hu W; Liu K; Wang T; Ma N; Liu X; Liu Y; Jiang Y
    PLoS One; 2013; 8(5):e63055. PubMed ID: 23650543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene.
    Xie LH; Sin FW; Cheng SC; Cheung YK; Chan KT; Xie Y; Xie Y
    Cancer Immunol Immunother; 2008 Jul; 57(7):1029-38. PubMed ID: 18157497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line.
    Yin XY; Wang L; Lu MD; Li BJ; Huang JF
    Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer.
    Lee HJ; Hong CY; Kim MH; Lee YK; Nguyen-Pham TN; Park BC; Yang DH; Chung IJ; Kim HJ; Lee JJ
    Exp Mol Med; 2012 Jan; 44(1):60-7. PubMed ID: 22089087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells.
    Sheng XL; Zhang H
    World J Gastroenterol; 2007 Nov; 13(44):5944-50. PubMed ID: 17990361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of murine tumour growth through CD8
    Kogo H; Shimizu M; Negishi Y; Uchida E; Takahashi H
    Immunology; 2017 Jul; 151(3):324-339. PubMed ID: 28294313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
    Gao J; Chen M; Peng ML; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytotoxicity of cytotoxic T lymphocytes induced by the dendritic cells phagocytosing PLA-AFP218-226 micospheres Against hepatocellular carcinoma cell lines].
    Zhang B; Chen W; Dong W; Cai MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):378-80, 448. PubMed ID: 16761412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma.
    Su H; Li B; Zheng L; Wang H; Zhang L
    Oncotarget; 2016 Jul; 7(30):48401-48411. PubMed ID: 27351282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.